Abionyx Pharma Financials
| ABNX Stock | EUR 1.24 0.02 1.64% |
Abionyx |
Understanding current and past Abionyx Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abionyx Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Abionyx Pharma's assets may result in an increase in income on the income statement.
Please note, the presentation of Abionyx Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Abionyx Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Abionyx Pharma's management manipulating its earnings.
Abionyx Pharma Stock Summary
Abionyx Pharma competes with Hydrogen Refueling, OSE Pharma, Biophytis, and Abivax SA. ABIONYX Pharma SA, a biopharmaceutical company, discovers and develops high density lipoprotein therapies for the treatment of cardiovascular and metabolic diseases. ABIONYX Pharma SA was founded in 2005 and is based in Labege, France. ABIONYX PHARMA is traded on Paris Stock Exchange in France.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0012616852 |
| Business Address | 33 43 av |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | abionyx.com |
| Phone | 33 5 62 24 97 06 |
| Currency | EUR - Euro |
You should never invest in Abionyx Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Abionyx Stock, because this is throwing your money away. Analyzing the key information contained in Abionyx Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Abionyx Pharma Key Financial Ratios
Abionyx Pharma's financial ratios allow both analysts and investors to convert raw data from Abionyx Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Abionyx Pharma over time and compare it to other companies across industries.Abionyx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abionyx Pharma's current stock value. Our valuation model uses many indicators to compare Abionyx Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abionyx Pharma competition to find correlations between indicators driving Abionyx Pharma's intrinsic value. More Info.Abionyx Pharma SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Abionyx Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Abionyx Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Abionyx Pharma SA Systematic Risk
Abionyx Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Abionyx Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Abionyx Pharma SA correlated with the market. If Beta is less than 0 Abionyx Pharma generally moves in the opposite direction as compared to the market. If Abionyx Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abionyx Pharma SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abionyx Pharma is generally in the same direction as the market. If Beta > 1 Abionyx Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Abionyx Pharma December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Abionyx Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abionyx Pharma SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abionyx Pharma SA based on widely used predictive technical indicators. In general, we focus on analyzing Abionyx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abionyx Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 13.99 | |||
| Value At Risk | (3.10) | |||
| Potential Upside | 5.56 |
Complementary Tools for Abionyx Stock analysis
When running Abionyx Pharma's price analysis, check to measure Abionyx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abionyx Pharma is operating at the current time. Most of Abionyx Pharma's value examination focuses on studying past and present price action to predict the probability of Abionyx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abionyx Pharma's price. Additionally, you may evaluate how the addition of Abionyx Pharma to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |